ENVESTNET ASSET MANAGEMENT INC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1407543 Berwyn, PA

Position in IDYA

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$8,352,542

-$187,973 QoQ

Shares Held

224,109

-12.6% QoQ

Ownership

0.232%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#56

of 286 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. IDYA ranks #20 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	487,627	$242,218,959
2	REGN	Regeneron Pharmaceuticals, Inc.	109,838	$68,488,386
3	EXEL	Exelixis, Inc.	949,669	$51,671,490
4	ARGX	Argenx SE	55,346	$51,348,358
5	ALNY	Alnylam Pharmaceuticals, Inc.	136,395	$41,058,986
6	INSM	INSMED Inc	336,997	$35,930,620
7	RPRX	Royalty Pharma plc	513,096	$28,769,292
8	ROIV	Roivant Sciences Ltd.	713,946	$25,266,548

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,352,542	224,109	-12.6%	Shares	Sole	2026-08-03
2026-03-31	$8,540,515	256,318	-7.7%	Shares	Sole	2026-05-04
2025-12-31	$9,595,249	277,560	-7.2%	Shares	Sole	2026-02-10
2025-09-30	$8,136,660	299,032	+174.0%	Shares	Sole	2025-11-05
2025-06-30	$2,294,438	109,155	+12.1%	Shares	Sole	2025-08-01
2025-03-31	$1,595,461	97,403	+0.1%	Shares	Sole	2025-04-29
2024-12-31	$2,499,864	97,271	-10.4%	Shares	Sole	2025-02-13
2024-09-30	$3,440,859	108,613	+3.9%	Shares	Sole	2024-11-07
2024-06-30	$3,670,855	104,553	+24.5%	Shares	Sole	2024-08-08
2024-03-31	$3,683,550	83,946	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.